免费日韩视频在线|亚洲老妇在线观看|自偷自自拍亚洲综合精品|日久精品不卡一区二区

<dl id="rpj8l"><noframes id="rpj8l"></noframes></dl>
<strike id="rpj8l"></strike>
    <ul id="rpj8l"></ul>
    <b id="rpj8l"></b>
    
    
    1. R&D Capability
      Home Innovation

      R&D Capability

      R&D Capability

      Remarkable R&D capabilities with over 20 years of R&D experience, Jiangsu Hansoh Pharma has several national-level R&D destinations, including the National Enterprise Technology Centers, Post-doctoral Research Station, and Key National Laboratory. The Company is highly efficient to discover innovative drugs, with R&D structure that covers areas such as peptides, biologics, small molecules, ADC drugs, and siRNAs.

      • 7
        launched innovative drugs
      • 40
        innovative drug candidates
      • 60 +
        clinical trials of innovative drug candidates being investigated
      • 60 +
        national scientific research projects such as 863 Program, Major Science and Technology Program for Innovation and Development of Significant New Drugs, and Torch Program
      • 2
        second prizes of National Science and Technology Progress Award
      • 2
        China Patent Gold Award
      • 600 +
        authorized invention patents at home and abroad
      • 200 +
        contributions to national standards
      R&D Team
      • 3
        State Council Special Allowance Experts
      • 16
        Jiangsu "innovative and entrepreneurial talent"
      • 9
        Jiangsu "333 talent project"
      • 1800 +
        R&D fellows in China and abroad